New drug combo aims to extend life in pancreatic cancer battle

NCT ID NCT06752811

First seen Feb 01, 2026 · Last updated Apr 23, 2026 · Updated 8 times

Summary

This study tests a new chemotherapy combination (paclitaxel polymeric micelles plus gemcitabine) against the current standard treatment for metastatic pancreatic cancer. About 416 adults with advanced pancreatic cancer who have not had prior treatment will take part. The goal is to see if the new combo helps people live longer without their cancer growing.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER METASTATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fudan University Shanghai Cancer Center

    RECRUITING

    Shanghai, Shanghai Municipality, 201400, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

  • Jiangsu Province Hospital

    RECRUITING

    Nanjing, Jiangsu, 210029, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.